EBITDA

Aura Minerals upgraded to BB- globally and brAA+ in Brazil by S&P, reflecting strong gold prices and growing production targets through 2026.

Chart Industries hit $1.01B adjusted EBITDA but major investor No Street Capital sold $53.7M stake, likely due to 9% underperformance versus S&P 500's 17% and pending Baker Hughes acquisition cap.

Tilray acquires BrewDog for £33M, creating ~$500M platform with projected $200M revenue and $6-8M EBITDA by 2027.

Delek US Holdings surged 5% after Q4 earnings showed strong refining margins and a turnaround to $143M profit from prior-year losses.

TransAlta posts strong 2025 results with $1.1B EBITDA and raises dividend 8%. Data centre demand accelerates growth through major partnership and strategic acquisitions.

IonQ stock jumped 21% on Q4 results beating guidance by 55% and robust 2026 revenue outlook, though the company remains unprofitable.

Caesars shares surged 19% amid multiple acquisition offers, including from Tilman Fertitta's firm. Strong Q4 revenue and record digital EBITDA highlight the company's growth potential.

Diversified Energy acquires $245M East Texas gas assets from Sheridan Production, adding 62 MMcfepd production and $52M projected EBITDA to strengthen regional operations.

Viridien reported strong 2025 results with 4% revenue growth and 21% EBITDA increase to $551 million. The company also announced leadership changes, appointing Henning Berg as new CEO.

Perimeter Solutions grew revenue 16% to $653M in 2025, but net loss widened to $206M due to $435M in founders advisory fees.

Circle's stock surged 35% after Q4 results showed reserve income up 69% and USDC stablecoin circulation doubled, reflecting strong digital currency adoption and operational efficiency gains.

ONEOK posts strong 2025 earnings but expects 2026 slowdown due to higher costs and lower commodity prices. Recovery anticipated in 2028 from major projects.

Carvana stock dropped 10% post-earnings as profitability concerns persist despite 58% revenue growth. Compressed margins and missed EBITDA expectations weigh on investor sentiment.

Gerdau posts steady Q4 results with R$2.4B EBITDA, authorizes R$4.7B investment plan for 2026, and launches new share repurchase program.

Surgery Partners shares fell 39.7% as major fund exits position amid high debt concerns, despite 6.6% revenue growth. Elevated leverage weighs on investor confidence.

BofA analyst bullish on DraftKings, projecting 2028 revenue of $8.5-9.1B from core business and emerging prediction markets, though near-term EBITDA will decline due to investments.

Sasol returns to positive free cash flow despite flat revenue from lower commodity prices. EBITDA declined 12%, but cost discipline improved working capital management.

Breach Inlet Capital acquires $9.8M stake in Frontdoor amid 14% revenue growth and 64% free cash flow surge, betting stock has been undervalued.

Tandem Diabetes surged after beating earnings expectations with a profitability turnaround. The insulin pump maker posted better-than-expected revenue and swung to adjusted profitability.

Burnham Holdings posts record $258.1M sales in 2025 but faces $21.5M full-year loss from legacy asbestos liabilities and pension charges. Adjusted metrics show improved underlying performance.